GlassScriptPhysician profile
Lori L Weinstein
NPI 1598866220
$2,769.25
in general payments reported to CMS, 2019-2025
23 companies · $516 in 2025
The $516 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,124 · 2022: $704 · 2023: $161 · 2024: $264 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $492.73 | 2021-2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $399.47 | 2021-2025 | Spravato |
| Astrazeneca Pharmaceuticals LP | $251.49 | 2021-2025 | Airsupra |
| Regeneron Healthcare Solutions, INC. | $226.31 | 2022 | |
| Philips North America LLC | $204.38 | 2022 | |
| Abiomed | $145.37 | 2025 | |
| Glaxosmithkline, LLC. | $129.95 | 2021 | |
| Genzyme Corporation | $129.20 | 2025 | |
| Novo Nordisk INC | $123.51 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.39 | 2022 | |
| Pfizer INC. | $107.86 | 2024 | |
| Axsome Therapeutics, INC. | $104.57 | 2024 | Sunosi |
| Amgen INC. | $90.61 | 2021 | |
| Sanofi-Aventis U.S. LLC | $79.80 | 2023 | |
| Mylan Specialty L.P. | $39.27 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $21.98 | 2021 | |
| Edwards Lifesciences Corporation | $18.99 | 2023 | Hemosphere |
| La Jolla Pharmaceutical Company | $18.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.79 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $15.37 | 2021 | |
| Resmed Corp | $13.76 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.69 | 2021 | |
| Advanced Respiratory, INC | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.